Sanara Medtech Inc
SMTI27.715USD
-0.155-0.56%
Cierre 11/07, 16:00（ET）Cotizaciones retrasadas 15 min
246.76MCap. mercado
PérdidaP/E TTM
Más Datos de Sanara Medtech Inc Compañía
Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. It markets several products for surgical and chronic wound care applications and has multiple products in its pipeline. Its surgical products, CellerateRX Surgical, TEXAGEN, BiFORM, ACTIGEN, ALLOCYTE, ALLOCYTE Plus Advanced Viable Bone Matrix (ALLOCYTE Plus), BIASURGE, FORTIFY TRG Tissue Repair Graft (FORTIFY TRG), and FORTIFY FLOWABLE Extracellular Matrix (FORTIFY FLOWABLE) are used in a range of surgical specialties to help promote patient healing and reduce the risk of complications. CellerateRX Surgical products, TEXAGEN products, FORTIFY TRG and FORTIFY FLOWABLE are used in specialties, including cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, and others.
Información de Sanara Medtech Inc
Símbolo de cotizaciónSMTI
Nombre de la empresaSanara Medtech Inc
Fecha de salida a bolsaApr 07, 1994
Director ejecutivoMr. Suresh V. (Sam) Muppalla
Número de empleados141
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 07
Dirección1200 Summit Avenue
CiudadFORT WORTH
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal76102
Teléfono18175292300
Sitio Webhttps://sanaramedtech.com/
Símbolo de cotizaciónSMTI
Fecha de salida a bolsaApr 07, 1994
Director ejecutivoMr. Suresh V. (Sam) Muppalla
Ejecutivos de Sanara Medtech Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
89.85K
+46.60%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
64.04K
--
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
22.70K
+14.12%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
20.80K
+18.70%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
17.66K
+25.52%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
9.39K
+53.64%
Mr. Keith G. Myers
Mr. Keith G. Myers
Independent Director
Independent Director
4.94K
+150.13%
Mr. Suresh V. (Sam) Muppalla
Mr. Suresh V. (Sam) Muppalla
President and Chief Executive Officer of Tissue Health Plus, LLC
President and Chief Executive Officer of Tissue Health Plus, LLC
2.97K
--
Mr. Jacob A. Waldrop
Mr. Jacob A. Waldrop
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Roszell Mack, III
Mr. Roszell Mack, III
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
89.85K
+46.60%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
64.04K
--
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
22.70K
+14.12%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
20.80K
+18.70%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
17.66K
+25.52%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
9.39K
+53.64%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
Por negocioUSD
Nombre
Ganancia
Proporción
Soft tissue repair products
22.66M
87.73%
Bone fusion products
3.14M
12.17%
SaaS
26.58K
0.10%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Soft tissue repair products
22.66M
87.73%
Bone fusion products
3.14M
12.17%
SaaS
26.58K
0.10%
Estadísticas de accionistas
Actualizado: mar., 28 de oct
Actualizado: mar., 28 de oct
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
FA Sanara, L.L.C.
39.45%
Stuckert (James W)
10.86%
Tall Pines Capital LLC
5.76%
Howell (Solomon Oden Jr)
5.51%
BlackRock Institutional Trust Company, N.A.
2.10%
Otro
36.32%
Accionistas
Accionistas
Proporción
FA Sanara, L.L.C.
39.45%
Stuckert (James W)
10.86%
Tall Pines Capital LLC
5.76%
Howell (Solomon Oden Jr)
5.51%
BlackRock Institutional Trust Company, N.A.
2.10%
Otro
36.32%
Tipos de accionistas
Accionistas
Proporción
Corporation
45.21%
Individual Investor
20.35%
Investment Advisor
6.43%
Investment Advisor/Hedge Fund
4.19%
Hedge Fund
0.78%
Research Firm
0.77%
Bank and Trust
0.11%
Pension Fund
0.11%
Otro
22.04%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
108
1.10M
12.39%
-50.86K
2025Q2
125
6.82M
76.76%
+464.64K
2025Q1
128
6.77M
77.90%
+391.75K
2024Q4
125
6.79M
77.72%
+603.56K
2024Q3
120
6.67M
76.37%
+483.73K
2024Q2
117
5.99M
68.68%
-126.89K
2024Q1
114
5.90M
70.54%
-174.47K
2023Q4
113
5.89M
70.53%
-138.63K
2023Q3
112
5.89M
70.55%
-196.98K
2023Q2
105
5.91M
70.95%
+122.70K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
FA Sanara, L.L.C.
3.51M
39.45%
--
--
Apr 11, 2025
Stuckert (James W)
966.97K
10.86%
--
--
Apr 11, 2025
Tall Pines Capital LLC
512.87K
5.76%
+512.87K
--
Sep 30, 2024
Howell (Solomon Oden Jr)
490.39K
5.51%
--
--
Apr 11, 2025
BlackRock Institutional Trust Company, N.A.
187.10K
2.1%
-6.12K
-3.17%
Jun 30, 2025
The Vanguard Group, Inc.
175.98K
1.98%
-20.48K
-10.43%
Jun 30, 2025
Stonebridge Wealth Management, LLC
119.66K
1.34%
+19.60K
+19.59%
Jun 30, 2025
Yon (Seth D)
89.85K
1.01%
+28.56K
+46.60%
Sep 15, 2025
Geode Capital Management, L.L.C.
77.74K
0.87%
-11.01K
-12.41%
Jun 30, 2025
Marshall Wace LLP
71.51K
0.8%
+42.24K
+144.28%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: jue., 6 de nov
Actualizado: jue., 6 de nov
Nombre
Proporción
Texas Capital Texas Small Cap Equity Index ETF
0.05%
WisdomTree US SmallCap Fund
0.03%
iShares Micro-Cap ETF
0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0%
Dimensional US Core Equity 1 ETF
0%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Ver más
Texas Capital Texas Small Cap Equity Index ETF
Proporción0.05%
WisdomTree US SmallCap Fund
Proporción0.03%
iShares Micro-Cap ETF
Proporción0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.01%
iShares Russell 2000 Growth ETF
Proporción0.01%
ProShares UltraPro Russell2000
Proporción0%
Dimensional US Core Equity 1 ETF
Proporción0%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporción0%
iShares Russell 2000 ETF
Proporción0%
Global X Russell 2000 Covered Call ETF
Proporción0%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
